Autolus Therapeutics plc (FRA:6A3A)
Germany · Delayed Price · Currency is EUR 1.290
-0.050 (-3.73%)
Last updated: Apr 24, 2026, 8:01 AM CET
Autolus Therapeutics Market Cap
Autolus Therapeutics has a market cap or net worth of €347.63 million as of April 24, 2026. Its market cap has increased by 20.77% in one year.
Market Cap
347.63M
Enterprise Value
382.52M
Revenue
64.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.29
Market Cap Chart
Since June 22, 2018, Autolus Therapeutics's market cap has decreased from 833.42M to 347.63M, a decrease of -58.29%. That is a compound annual growth rate of -10.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 347.63M | -22.94% |
| Dec 31, 2025 | 451.08M | -25.33% |
| Dec 31, 2024 | 604.06M | -40.39% |
| Dec 29, 2023 | 1.01B | 229.38% |
| Dec 30, 2022 | 307.67M | -7.54% |
| Dec 31, 2021 | 332.77M | -12.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 22, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biotest Aktiengesellschaft | 1.45B |
| Darwin AG | 92.40M |
| 2invest AG | 49.52M |
| Biomark Diagnostics | 35.52M |
| co.don AG | 374.13K |
| Paion AG | 278.21K |
| bioXXmed AG | 244.68K |
| MagForce AG | 122.29K |